Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Central American Bank for Economic Integration $1.35 billion notes offering
The notes are due 2027
China National Petroleum RMB1 billion guaranteed bonds offering
We advised CNPC on the offering
Bank of America $5 billion fixed-to-floating-rate notes
The investment-grade notes are due 2035
Banco Santander Chile CHF225 million notes offering
We advised Banco Santander Chile on the Regulation S offering
Telefónica $500 million tender offer
We advised Telefónica on its tender offer for three series of notes
Morgan Stanley Bank $2 billion senior notes offering
We advised Morgan Stanley Bank on its 3(a)(2) notes offering
Immatics $201 million follow-on offering
We advised Immatics on the offering of shares
IDEAYA Biosciences $350 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Morgan Stanley $4.75 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Alector $75 million stock offering
The common stock is listed on the Nasdaq Global Select Market